Financhill
Back

MEI Pharma Quote, Financials, Valuation and Earnings

MEI Pharma Price Quote

$2.50

MEI Pharma Key Stats

Sell
34
MEI Pharma (MEIP) is a Sell

Day range:
$2.46 - $2.50
52-week range:
$2.43 - $6.39
Dividend yield:
0%
P/E ratio:
0.94
P/S ratio:
0.16
P/B ratio:
0.67%

Volume:
114.9K
Avg. volume:
23.1K
1-year change:
-59.45%
Market cap:
$16.7M
Revenue:
$65.3M
EPS:
$-6.99

How Much Does MEI Pharma Make?

Data Unavailable

Is MEI Pharma Growing As A Company?

Data Unavailable

MEI Pharma Stock Price Performance

  • Did MEI Pharma Stock Go Up Last Month?
    MEI Pharma share price went down by -10.71% last month
  • Did MEIP's Share Price Rise Over The Last Year?
    MEIP share price fell by -59.45% over the past 1 year

What Is MEI Pharma 52-Week High & Low?

  • What Is MEI Pharma’s 52-Week High Share Price?
    MEI Pharma has traded as high as $6.39 over the past 52 weeks
  • What Is MEI Pharma’s 52-Week Low Share Price?
    MEI Pharma has traded as low as $2.43 over the past 52 weeks

MEI Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy MEI Pharma?

Data Unavailable

Is MEI Pharma Cash Flow Positive?

Data Unavailable

MEI Pharma Return On Invested Capital

Data Unavailable

MEI Pharma Earnings Date & Stock Price

  • What Is MEI Pharma's Stock Price Today?
    A single share of MEIP can be purchased today for 2.50
  • What Is MEI Pharma’s Stock Symbol?
    MEI Pharma trades on the nasdaq under the ticker symbol: MEIP
  • When Is MEI Pharma’s Next Earnings Date?
    The next quarterly earnings date for MEI Pharma is scheduled on February 13, 2025
  • When Is MEIP's next ex-dividend date?
    MEI Pharma's next ex-dividend date is November 16, 2023
  • How To Buy MEI Pharma Stock?
    You can buy MEI Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

MEI Pharma Competitors

  • Who Are MEI Pharma's Competitors?
    Below is a list of companies who compete with MEI Pharma or are related in some way:
    • Evoke Pharma Inc (EVOK)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Revance Therapeutics Inc (RVNC)

MEI Pharma Dividend Yield

Data Unavailable

MEI Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 19.56%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable